A citation-based method for searching scientific literature

Meera Soundararajan, Annette K Roos, Pavel Savitsky, Panagis Filippakopoulos, Arminja N Kettenbach, Jesper V Olsen, Scott A Gerber, Jeyanthy Eswaran, Stefan Knapp, Jonathan M Elkins. Structure 2013
Times Cited: 97







List of co-cited articles
840 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site.
Katrin de Graaf, Hanna Czajkowska, Sabine Rottmann, Len C Packman, Richard Lilischkis, Bernhard Lüscher, Walter Becker. BMC Biochem 2006
63
11

PHENIX: a comprehensive Python-based system for macromolecular structure solution.
Paul D Adams, Pavel V Afonine, Gábor Bunkóczi, Vincent B Chen, Ian W Davis, Nathaniel Echols, Jeffrey J Headd, Li-Wei Hung, Gary J Kapral, Ralf W Grosse-Kunstleve,[...]. Acta Crystallogr D Biol Crystallogr 2010
7

Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors.
Christian Schmitt, Dagmar Kail, Marica Mariano, Martin Empting, Nadja Weber, Tamara Paul, Rolf W Hartmann, Matthias Engel. PLoS One 2014
33
21

Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitors.
Oussama Dehbi, Abdellatif Tikad, Stéphane Bourg, Pascal Bonnet, Olivier Lozach, Laurent Meijer, Mina Aadil, Mohammed Akssira, Gérald Guillaumet, Sylvain Routier. Eur J Med Chem 2014
26
26


Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.
Brian J O'Roak, Laura Vives, Wenqing Fu, Jarrett D Egertson, Ian B Stanaway, Ian G Phelps, Gemma Carvill, Akash Kumar, Choli Lee, Katy Ankenman,[...]. Science 2012
854
7

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases.
Vassilios Myrianthopoulos, Marina Kritsanida, Nicolas Gaboriaud-Kolar, Prokopios Magiatis, Yoan Ferandin, Emilie Durieu, Olivier Lozach, Daniel Cappel, Meera Soundararajan, Panagis Filippakopoulos,[...]. ACS Med Chem Lett 2013
49
14

A helix scaffold for the assembly of active protein kinases.
Alexandr P Kornev, Susan S Taylor, Lynn F Ten Eyck. Proc Natl Acad Sci U S A 2008
293
7

Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk).
Andrew S Rosenthal, Cordelle Tanega, Min Shen, Bryan T Mott, James M Bougie, Dac-Trung Nguyen, Tom Misteli, Douglas S Auld, David J Maloney, Craig J Thomas. Bioorg Med Chem Lett 2011
55
12

Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A.
Javier Fernandez-Martinez, Eva M Vela, Mireille Tora-Ponsioen, Oscar H Ocaña, M Angela Nieto, Juan Galceran. J Cell Sci 2009
55
12

Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A.
Fayçal Guedj, Catherine Sébrié, Isabelle Rivals, Aurelie Ledru, Evelyne Paly, Jean C Bizot, Desmond Smith, Edward Rubin, Brigitte Gillet, Mariona Arbones,[...]. PLoS One 2009
142
7

The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
J H Sitz, K Baumgärtel, B Hämmerle, C Papadopoulos, P Hekerman, F J Tejedor, W Becker, B Lutz. Neuroscience 2008
56
12


DYRK protein kinases.
Ulf Soppa, Walter Becker. Curr Biol 2015
31
22

Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1.
Junhao Mao, Peter Maye, Priit Kogerman, Francisco J Tejedor, Rune Toftgard, Wei Xie, Guanqing Wu, Dianqing Wu. J Biol Chem 2002
146
7

The MNB/DYRK1A protein kinase: genetic and biochemical properties.
J Galceran, K de Graaf, F J Tejedor, W Becker. J Neural Transm Suppl 2003
61
11

The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2.
Florian Glenewinkel, Michael J Cohen, Cason R King, Sophie Kaspar, Simone Bamberg-Lemper, Joe S Mymryk, Walter Becker. Sci Rep 2016
26
26



DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.
Naoe Taira, Keishi Nihira, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida. Mol Cell 2007
210
7

Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling.
Frank Wippich, Bernd Bodenmiller, Maria Gustafsson Trajkovska, Stefanie Wanka, Ruedi Aebersold, Lucas Pelkmans. Cell 2013
359
7

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature.
Thu Lan Nguyen, Corinne Fruit, Yann Hérault, Laurent Meijer, Thierry Besson. Expert Opin Ther Pat 2017
35
20


Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity.
Kunal Kumar, Peter Man-Un Ung, Peng Wang, Hui Wang, Hailing Li, Mary K Andrews, Andrew F Stewart, Avner Schlessinger, Robert J DeVita. Eur J Med Chem 2018
24
29

Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors.
Anna Czarna, Jinhua Wang, Diana Zelencova, Yao Liu, Xianming Deng, Hwan Geun Choi, Tinghu Zhang, Wenjun Zhou, Jae Won Chang, Hanne Kildalsen,[...]. J Med Chem 2018
18
38

A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.
Julia Roewenstrunk, Chiara Di Vona, Jie Chen, Eva Borras, Chao Dong, Krisztina Arató, Eduard Sabidó, Michael S Y Huen, Susana de la Luna. Sci Rep 2019
17
41

DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth.
Jeroni Luna, Jacopo Boni, Miriam Cuatrecasas, Xavier Bofill-De Ros, Estela Núñez-Manchón, Meritxell Gironella, Eva C Vaquero, Maria L Arbones, Susana de la Luna, Cristina Fillat. Gut 2019
35
20

Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Dnyandev B Jarhad, Karishma K Mashelkar, Hong-Rae Kim, Minsoo Noh, Lak Shin Jeong. J Med Chem 2018
50
14

Deep evolutionary conservation of an intramolecular protein kinase activation mechanism.
Jingfen Han, Diego Miranda-Saavedra, Nathan Luebbering, Aman Singh, Gary Sibbet, Michael A J Ferguson, Vaughn Cleghon. PLoS One 2012
16
37


dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila.
Pamela A Lochhead, Gary Sibbet, Ross Kinstrie, Tava Cleghon, Margie Rylatt, Deborah K Morrison, Vaughn Cleghon. Biochem J 2003
35
17

Unusual function of the activation loop in the protein kinase DYRK1A.
Stephan Wiechmann, Hanna Czajkowska, Katrin de Graaf, Joachim Grötzinger, Hans-Georg Joost, Walter Becker. Biochem Biophys Res Commun 2003
33
18

A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation.
Pamela A Lochhead, Ross Kinstrie, Gary Sibbet, Teeara Rawjee, Nick Morrice, Vaughn Cleghon. Mol Cell 2006
204
6

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
Alex N Bullock, Sanjan Das, Judit E Debreczeni, Peter Rellos, Oleg Fedorov, Frank H Niesen, Kunde Guo, Evangelos Papagrigoriou, Ann L Amos, Suhyung Cho,[...]. Structure 2009
77
7

XDS.
Wolfgang Kabsch. Acta Crystallogr D Biol Crystallogr 2010
6

The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development.
Ariadna Laguna, Sergi Aranda, María José Barallobre, Rima Barhoum, Eduardo Fernández, Vassiliki Fotaki, Jean Maurice Delabar, Susana de la Luna, Pedro de la Villa, Maria L Arbonés. Dev Cell 2008
88
6

Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4.
Christian Schmitt, Parisa Miralinaghi, Marica Mariano, Rolf W Hartmann, Matthias Engel. ACS Med Chem Lett 2014
36
16

Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A.
Stefania Sarno, Marco Mazzorana, Ryan Traynor, Maria Ruzzene, Giorgio Cozza, Mario A Pagano, Flavio Meggio, Giuseppe Zagotto, Roberto Battistutta, Lorenzo A Pinna. Cell Mol Life Sci 2012
21
28

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
Xiaomin Yin, Nana Jin, Jianlan Gu, Jianhua Shi, Jianhua Zhou, Cheng-Xin Gong, Khalid Iqbal, Inge Grundke-Iqbal, Fei Liu. J Biol Chem 2012
67
8

Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.
Alicia Foucourt, Damien Hédou, Carole Dubouilh-Benard, Angélique Girard, Thierry Taverne, Anne-Sophie Casagrande, Laurent Désiré, Bertrand Leblond, Thierry Besson. Molecules 2014
28
21


Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome.
Noriko Murakami, Wen Xie, Renne Chen Lu, Mo-Chou Chen-Hwang, Andrzej Wieraszko, Yu Wen Hwang. J Biol Chem 2006
51
11

Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Jingchun Gao, Zhong Zheng, Bhupendra Rawal, Michael J Schell, Gerold Bepler, Eric B Haura. Cancer Biol Ther 2009
37
16

Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.
Stephen E Mercer, Daina Z Ewton, Xiaobing Deng, Seunghwan Lim, Thomas R Mazur, Eileen Friedman. J Biol Chem 2005
72
8

DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome.
Sònia Najas, Juan Arranz, Pamela A Lochhead, Anne L Ashford, David Oxley, Jean M Delabar, Simon J Cook, María José Barallobre, Maria L Arbonés. EBioMedicine 2015
42
14

A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
Anne L Ashford, David Oxley, Jason Kettle, Kevin Hudson, Sylvie Guichard, Simon J Cook, Pamela A Lochhead. Biochem J 2014
39
15

Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons.
M Martinez de Lagran, R Benavides-Piccione, I Ballesteros-Yañez, M Calvo, M Morales, C Fillat, J Defelipe, G J A Ramakers, M Dierssen. Cereb Cortex 2012
53
11

DYRK1A mutations in two unrelated patients.
Lyse Ruaud, Cyril Mignot, Agnès Guët, Christelle Ohl, Caroline Nava, Delphine Héron, Boris Keren, Christel Depienne, Valérie Benoit, Isabelle Maystadt,[...]. Eur J Med Genet 2015
22
27

DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.
Samira Abu Jhaisha, Esti W Widowati, Isao Kii, Rie Sonamoto, Stefan Knapp, Chrisovalantis Papadopoulos, Walter Becker. Sci Rep 2017
15
40

Autism-associated Dyrk1a truncation mutants impair neuronal dendritic and spine growth and interfere with postnatal cortical development.
T Dang, W Y Duan, B Yu, D L Tong, C Cheng, Y F Zhang, W Wu, K Ye, W X Zhang, M Wu,[...]. Mol Psychiatry 2018
36
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.